Sign in

You're signed outSign in or to get full access.

Brittany Socha

Research Analyst at Piper Sandler

Brittany Socha is an Equity Research Associate at Piper Sandler, specializing in biotechnology and pharmaceuticals. She has been referenced in earnings coverage for companies such as Day One Biopharmaceuticals. Limited public information is available on her performance metrics, career timeline, previous experience, or professional credentials such as FINRA registrations.

Brittany Socha's questions to Day One Biopharmaceuticals (DAWN) leadership

Question · Q4 2025

Brittany Socha asked about physician feedback on the three-year FIREFLY data, how much of Q4 2025 OJEMDA sales growth was attributable to this data, and when the bulk of its impact on sales figures is expected.

Answer

CCO Lauren Merendino reported very positive physician responses to the three-year FIREFLY-1 data, especially regarding time to next treatment. She stated that the impact on Q4 2025 performance was minimal, as awareness was primarily within the KOL community. The bulk of the impact is expected in 2026, following broader education and a peer-reviewed publication, which will enable active promotion.

Ask follow-up questions

Fintool

Fintool can predict Day One Biopharmaceuticals logo DAWN's earnings beat/miss a week before the call

Question · Q4 2025

Brittany Socha asked about physician feedback on the three-year FIREFLY-1 data, the attributed impact of this data on Q4 2025 OJEMDA sales growth, and when the main sales impact is expected.

Answer

CEO Jeremy Bender directed the question to CCO Lauren Merendino. Lauren Merendino reported very positive physician feedback from KOLs at the SNO conference, particularly regarding the extended time to next treatment. She stated that the impact on Q4 performance was minimal due to the timing (just before Thanksgiving) and limited awareness beyond KOLs. She expects broader impact in 2026, especially after a peer-reviewed publication allows for active promotion and wider physician education.

Ask follow-up questions

Fintool

Fintool can write a report on Day One Biopharmaceuticals logo DAWN's next earnings in your company's style and formatting